Skip directly to site content Skip directly to search
Español | Other Languages
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
Healthcare-Associated Infections (HAIs)
    CDC Home

    HAI/AR Program Activities

    Minus
    Related Pages

    CDC awards funding to 64 state, local, territorial, and U.S.-affiliated health departments to support healthcare-associated infections and antimicrobial resistance (HAI/AR) activities. Learn what health departments are doing to prevent and control HAI/AR by navigating to any of the pages below.

    Response and Prevention

    Preventing and containing HAI/AR outbreaks and threats

    Antimicrobial Resistance Laboratory Network (AR Lab Network)

    Bolstering the nation’s ability to detect and respond to antibiotic resistance

    National Healthcare Safety Network (NHSN)

    Strengthening the nation’s most widely used HAI tracking system

    Antibiotic Stewardship

    Measuring and improving how antibiotics are prescribed

    Infection Prevention and Control (IPC) Education and Training

    Teaching and training the infection prevention workforce

    Strike Team and Infrastructure Support for Nursing Homes and Other Long-term Care Facilities

    Providing additional subject matter expertise and resources to facilities like nursing homes and long-term care hospitals

    Top of Page
    Last Reviewed: March 1, 2023
    Source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP)
    • Facebook
    • Twitter
    • LinkedIn
    • Syndicate
    homeHealthcare-associated Infections (HAI)
    • HAI Dataplus icon
      • Data Portalplus icon
        • Current HAI Progress Report
        • Progress Report FAQs
        • Antibiotic Resistance & Patient Safety Portal
        • COVID-19 Impact on HAIs
      • Data Archiveplus icon
        • 2020 HAI Progress Report
        • 2019 HAI Progress Report
        • 2018 HAI Progress Report
        • 2017 HAI Progress Report
        • 2016 HAI Progress Report
        • Data Summary: Assessing Progress 2006-2016
        • 2015 HAI Data Report
        • 2015 SIRs Using Historical Baselines
        • 2014 HAI Progress Report
        • Technical Appendix for Stop Spread of Antibiotic Resistance
    • Types of Infectionsplus icon
      • Central Line-associated Bloodstream Infectionsplus icon
        • Resources for Patients & Providers
        • FAQs about Catheters
      • Surgical Site Infectionplus icon
        • FAQs about SSIs
      • Catheter-associated Urinary Tract Infectionplus icon
        • FAQs about CAUTI
      • Ventilator-associated Pneumoniaplus icon
        • FAQs about VAP
    • Diseases and Organismsplus icon
      • Acinetobacter
      • Burkholderia cepacia
      • Clostridioides difficile
      • Clostridium Sordellii
      • Carbapenem-resistant Enterobacterales (CRE)plus icon
        • Patients
        • FAQs about CRE for Pet Owners
        • Clinicians
        • FAQs about CRE for Vets
        • Healthcare Facilities
        • Public Health Departments
        • CRE Technical Information
        • Tracking CRE in the United States
      • ESBL-producing Enterobacterales
      • Gram-negative Bacteria
      • Hepatitis
      • HIVplus icon
        • Occupationally Acquired HIV/AIDS in Healthcare Personnel
      • Klebsiella
      • MRSA
      • Nontuberculous Mycobacteria (NTM)plus icon
        • Clinicians
        • Healthcare Facilities
        • Health Departments
        • Mycobacterium abscessus
      • Norovirus
      • Pseudomonas aeruginosaplus icon
        • Tracking Carbapenem-Resistant Pseudomonas aeruginosa
      • Staphylococcus aureus
      • Tuberculosis
      • VISA / VRSA
      • Vancomycin-resistant Enterococci (VRE) in Healthcare Settings
    • Preventing HAIsplus icon
      • Staph BSI Prevention Strategies
      • CDI Prevention Strategies
      • Urine Culture Stewardshipplus icon
        • Patients with Indwelling Urinary Catheterplus icon
          • Survey
          • Structure
          • Strategize
          • Sustain
        • Patients without Indwelling Urinary Catheter
      • Targeted Assessment for Prevention (TAP)plus icon
        • TAP CAUTI Implementation Guide
        • TAP CDI Implementation Guide
        • TAP CLABSI Implementation Guide
        • Infection Prevention Champions
      • Prevention Toolkitsplus icon
        • Options for Evaluating Environmental Cleaning
        • Appendices to the Conceptual Program Model for Environmental Evaluation
      • Basic Infection Control and Prevention Plan for Outpatient Oncology Settingsplus icon
        • Appendices
      • Outpatient Care Guide
      • Occupationally Acquired Infectionsplus icon
        • Archive
      • Infection Control Assessment Toolsplus icon
        • Infection Prevention and Control Assessment Tool for Nursing Homes Preparing for COVID-19
      • Environmental Cleaning in Resource-Limited Settingsplus icon
        • Key Definitions & Abbreviations
        • Introduction
        • Cleaning Programs
        • Environmental Cleaning Supplies and Equipment
        • Environmental Cleaning Procedures
        • Conclusion & Further Reading
        • References
        • Appendix A: Risk-assessment
        • Appendix B1: Cleaning – general areas
        • Appendix B2: Cleaning – specialized areas
        • Appendix C: Examples of high-touch surfaces
        • Appendix D: Linen and laundry management
        • Appendix E: Chlorine disinfectant preparation
      • Healthcare Environmental Infection Preventionplus icon
        • Reduce Risk from Water
        • Reduce Risk from Surfaces
        • Environmental Cleaning in Resource-Limited Settings
    • MDRO Guidesplus icon
      • Prevention Strategies
      • Containment Strategy
      • What Can Be Done
      • Case Studies
      • PPE in Nursing Homesplus icon
        • Frequently Asked Questions (FAQs)
    • Health Department HAI/AR Programsplus icon
      • HAI Program Activitiesplus icon
        • Response & Prevention
        • Antibiotic Stewardship
        • Antibiotic Resistance Laboratory Network (AR Lab Network)
        • IPC Education & Training
        • National Healthcare Safety Network
        • Strike Team Support
      • HAI/AR Program Successes & Public Health Impact
      • Recipient Health Departments & Funding
      • Resources for HAI/AR Programsplus icon
        • HAI/AR Accreditation Crosswalk
        • Interim Local Health Department (LHD) HAI/AR Strategy
        • Strengthening Partner Networks
        • Coordinating with Policymakers
    • Researchplus icon
      • CDC Supported Projects
      • Prevention Epicenters (PE)
      • Healthcare Safety Research (SHEPheRD)plus icon
        • Current Shepherd Webinars
      • Environmental Hygiene in Healthcare
      • Modeling Infectious Diseases in Healthcare Network (MInD – Healthcare)plus icon
        • Past Awardees
    • Patient Safetyplus icon
      • Antibiotic Resistant Germs in Hospitals
    • Outpatient Settings
    • Laboratory Resourcesplus icon
      • Reference AST Data
      • Multiplex Real-Time PCR Detection of KPC & NDM-1 genes
      • Quinolones and the Clinical Lab
      • VRE and the Clinical Laboratory
      • Detection of Imipenem or Meropenem-resistance in Gram-negative Organisms
      • Detection of: Oxacillin/MRSA
      • Detection of VISA/VRSAplus icon
        • S.E.A.R.C.H.
      • Labs Role in the Search and Containment of VRSA
      • Detection of Coagulase-negative Staphylococcus species with Decreased Susceptibility
      • VISA/VRSA Lab Testing Algorithm
      • Use of an Inferred PFGE Algorithm
      • Inferred Identification of Pulsed Field Types based on MLST clonal complex
    • Outbreak and Patient Notificationsplus icon
      • Pseudomonas aeruginosa – Artificial Tears
      • B. cepacia – Ultrasound Gel
      • Tuberculosis – Bone Allograft Material
      • B. cepacia – Saline Flush
      • Contaminated Heater-Cooler Devices
      • B. cepacia – Docusate
      • CDC Statement LA CRE
      • Stem Cell and Exosome Products
      • Pseudomonas aeruginosa
      • Multistate Meningitis Outbreakplus icon
        • Meningitis Case Counts
        • Meningitis State Facilities Map
        • Resources for Clinicians
        • Resources for Patients
        • Resources for Laboratories
        • Infographic
        • Microscopic Gallery of Pathologic Results
      • Outbreaks in Outpatient Settingsplus icon
        • 2007-2009 (Archived)
      • Outbreak Resources for State Health Departmentsplus icon
        • Evaluating an Infection Control Breach
        • Outbreak Toolkit
    • CDC HAI Commentaries
    email_03Get Email Updates

    To receive email updates about this page, enter your email address:

    What's this?
    • About CDC
    • Contact Us
    • 800-232-4636
    Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
    CONTACT CDC
    Contact Us
    Call 800-232-4636
    Email Us
    ABOUT CDC
    • About CDC
    • Jobs
    • Funding
    POLICIES
    • Accessibility
    • External Links
    • Privacy
    • Policies
    • No Fear Act
    • FOIA
    • OIG
    • Nondiscrimination
    • Vulnerability Disclosure Policy
    CONNECT WITH US
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Youtube
    • Pinterest
    • Snapchat
    • Email
    LANGUAGES
    • Español
    • 繁體中文
    • Tiếng Việt
    • 한국어
    • Tagalog
    • Русский
    • العربية
    • Kreyòl Ayisyen
    • Français
    • Polski
    • Português
    • Italiano
    • Deutsch
    • 日本語
    • فارسی
    • English
    • U.S. Department of Health & Human Services
    • Accessibility
    • External Links
    • Privacy
    • Policies
    • No Fear Act
    • FOIA
    • Nondiscrimination
    • OIG
    • Vulnerability Disclosure Policy
    • USA.gov
    SAS stats

    Exit Notification / Disclaimer Policy

    Links with this icon indicate that you are leaving the CDC website.
    • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
    • Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
    • You will be subject to the destination website's privacy policy when you follow the link.
    • CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
    For more information on CDC's web notification policies, see Website Disclaimers.
    CDC.gov Privacy Settings

    We take your privacy seriously. You can review and change the way we collect information below.

    These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

    Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.

    Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.

    Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.

    Remove all
    Confirmed!

    Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.

    Close